Details for Patent: 11,027,031
✉ Email this page to a colleague
Which drugs does patent 11,027,031 protect, and when does it expire?
Patent 11,027,031 protects ILLUCCIX and is included in one NDA.
This patent has forty-two patent family members in eighteen countries.
Summary for Patent: 11,027,031
| Title: | Kit for radiolabelling |
| Abstract: | The present invention relates to a kit for radiolabelling a targeting agent with gallium-68. The present invention also relates to the use of the kit for radiolabelling a targeting agent, and a method for radiolabelling a targeting agent with gallium-68 using the kit. |
| Inventor(s): | Wouters; Ludovic (Herve, BE), Kaisin; Geoffroy (Seraing, BE), Luxen; Andre (Ocquier-Clavier, BE), Leonard; Marc (Flemalle, BE), Voccia; Samuel (Liege, BE) |
| Assignee: | ANMI S.A. (Liege, BE) |
| Application Number: | 16/532,526 |
|
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 11,027,031
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Telix | ILLUCCIX | gallium ga-68 gozetotide | POWDER;INTRAVENOUS | 214032-001 | Dec 17, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,027,031
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Belgium | 2014/0653 | Aug 29, 2014 |
International Family Members for US Patent 11,027,031
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015309187 | ⤷ Try a Trial | |||
| Australia | 2015309188 | ⤷ Try a Trial | |||
| Australia | 2020220193 | ⤷ Try a Trial | |||
| Australia | 2020220194 | ⤷ Try a Trial | |||
| Australia | 2022202346 | ⤷ Try a Trial | |||
| Australia | 2022202439 | ⤷ Try a Trial | |||
| Belgium | 1021191 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
